Brief: Genedx Announces Closing Of Underwritten Public Offering And Concurrent Registered Direct Offering
31/01/2023 22:56
Jan 31 (Reuters) -
* GENEDX ANNOUNCES CLOSING OF UNDERWRITTEN PUBLIC OFFERING
AND
CONCURRENT REGISTERED DIRECT OFFERING
Source text for Eikon: ID:nGNX1xJ3wV
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GeneDx Holdings
See all newsBrief: Genedx Launches New Online Offering For Families To Improve Accessibility Of Exome Testing For Children
GeneDx Holdings Corp reports results for the quarter ended June 30 - Earnings Summary
GeneDx Q2 revenue beats analyst estimates
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, GE Healthcare, Synopsys
Brief: Genedx Names Mark Gardner President To Lead Its Next Phase Of Scale And Growth